0.00Open3.33Pre Close0 Volume25 Open Interest15.00Strike Price0.00Turnover109.42%IV6.08%PremiumDec 20, 2024Expiry Date2.28Intrinsic Value100Multiplier8DDays to Expiry1.05Extrinsic Value100Contract SizeAmericanOptions Type0.8210Delta0.0928Gamma6.91Leverage Ratio-0.0468Theta0.0026Rho5.67Eff Leverage0.0067Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet